跳至主要内容
临床试验/NCT01152372
NCT01152372已完成1 期

Experimental Medicine Study to Validate the Modified Glucose Disposal Test in Healthy Subjects and Subjects With Type 2 Diabetes

Bristol-Myers Squibb2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2010年6月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
36
试验地点
2
主要终点
Glucose (labeled and unlabeled), insulin and c-peptide will be measured to calculate insulin sensitivity, endogenous glucose production and insulin secretion

研究概览

简要总结

Evaluate the modified GDT as a measure of key metabolic characteristics in healthy subjects and those with type 2 diabetes mellitus

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of Type 2 diabetes
  • Clinically healthy
  • Drug naive or on a stable dose of metformin monotherapy and/or a secretagogue

排除标准

  • Type 1 Diabetes
  • History of significant heart disease.
  • Bariatric surgery
  • Exposure to fibrates, thiazolidinediones, insulin, exenatide, pramlintide or DPP-IV inhibitors

结局指标

主要结局

Glucose (labeled and unlabeled), insulin and c-peptide will be measured to calculate insulin sensitivity, endogenous glucose production and insulin secretion

时间窗: within 24 hours

次要结局

  • Characterize the patterns of intermediate metabolites in healthy subjects and subjects with type 2 diabetes mellitus(within 24 hours)

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验